Improving consistency for a Mefenamic acid immediate release formulation

Elke Prasad; John Robertson; Gavin W. Halbert

Improving consistency for a Mefenamic acid immediate release formulation

Elke Prasad, John Robertson, Gavin W. Halbert

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Research output: Contribution to conference › Poster

5 Citations (Scopus)

28 Downloads (Pure)

Abstract

Mefenamic acid (MFA) product performance is highly dependant on particle size and can lead to variable efficacy. In this study, a structured development program was applied, developing a crystalline solid dispersion (CSD) formulation, retaining API properties and improving performance consistency compared to a commercial product.

Original language	English
Number of pages	1
Publication status	Published - 22 Oct 2020
Event	CMAC Annual Open Day - Virtual event, Glasgow, United Kingdom Duration: 21 Oct 2020 → 22 Oct 2020

Conference

Conference	CMAC Annual Open Day
Country/Territory	United Kingdom
City	Glasgow
Period	21/10/20 → 22/10/20

Keywords

Mefenamic acid
MFA
rheology screening
hot-melt-extrusion
crystalline solid dispersion (CSD)

Access to Document

Elke-etal-CMAC-2020-Improving-consistency-for-a-mefenamic-acid-immediate-release-formationOther version, 2.37 MBLicence: CC BY-NC 4.0

5 Citations
1 Article

Improving consistency for a Mefenamic acid immediate release formulation
Prasad, E., Robertson, J. & Halbert, G., 25 Aug 2020, (E-pub ahead of print) In: Journal of Pharmaceutical Sciences.
Research output: Contribution to journal › Article › peer-review

Open Access
File
61 Downloads (Pure)

Cite this

@conference{202a7e81bf934c50835d66a3e18a7f15,

title = "Improving consistency for a Mefenamic acid immediate release formulation",

abstract = "Mefenamic acid (MFA) product performance is highly dependant on particle size and can lead to variable efficacy. In this study, a structured development program was applied, developing a crystalline solid dispersion (CSD) formulation, retaining API properties and improving performance consistency compared to a commercial product.",

keywords = "Mefenamic acid, MFA, rheology screening, hot-melt-extrusion, crystalline solid dispersion (CSD)",

author = "Elke Prasad and John Robertson and Halbert, {Gavin W.}",

year = "2020",

month = oct,

day = "22",

language = "English",

note = "CMAC Annual Open Day ; Conference date: 21-10-2020 Through 22-10-2020",

}

TY - CONF

T1 - Improving consistency for a Mefenamic acid immediate release formulation

AU - Prasad, Elke

AU - Robertson, John

AU - Halbert, Gavin W.

PY - 2020/10/22

Y1 - 2020/10/22

N2 - Mefenamic acid (MFA) product performance is highly dependant on particle size and can lead to variable efficacy. In this study, a structured development program was applied, developing a crystalline solid dispersion (CSD) formulation, retaining API properties and improving performance consistency compared to a commercial product.

AB - Mefenamic acid (MFA) product performance is highly dependant on particle size and can lead to variable efficacy. In this study, a structured development program was applied, developing a crystalline solid dispersion (CSD) formulation, retaining API properties and improving performance consistency compared to a commercial product.

KW - Mefenamic acid

KW - MFA

KW - rheology screening

KW - hot-melt-extrusion

KW - crystalline solid dispersion (CSD)

M3 - Poster

T2 - CMAC Annual Open Day

Y2 - 21 October 2020 through 22 October 2020

ER -

Improving consistency for a Mefenamic acid immediate release formulation

Abstract

Conference

Keywords

Access to Document

Fingerprint

Research output

Improving consistency for a Mefenamic acid immediate release formulation

Cite this